Kumar, G., et al., Emerging trends of herbal care in dentistry. Journal of clinical and diagnostic research: JCDR, 2013. 7(8): p. 1827.

Skalli, S. and S.A. Jordan, Herbal and traditional medicines, now and future, in Pharmacovigilance. 2017, Springer. p. 145-159.

Jung, J., M. Hermanns-Clausen, and W. Weinmann, Anorectic sibutramine detected in a Chinese herbal drug for weight loss. Forensic science international, 2006. 161(2-3): p. 221-222.

Posadzki, P., L. Watson, and E. Ernst, Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews. European journal of clinical pharmacology, 2013. 69(3): p. 295-307.

Routledge, P.A., The European Herbal Medicines Directive. Drug safety, 2008. 31(5): p. 416-418.

Brown, A.C., An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series. Food Chem Toxicol, 2017. 107(Pt A): p. 449-471.

Foroughi, M.H., et al., Identification of undeclared active pharmaceutical ingredients in counterfeit herbal medicines used as opioid substitution therapy. Australian journal of forensic sciences, 2017. 49(6): p. 720-729.

Höllein, L., et al., Routine quality control of medicines in developing countries: analytical challenges, regulatory infrastructures and the prevalence of counterfeit medicines in Tanzania. TrAC Trends in Analytical Chemistry, 2016. 76: p. 60-70.

Mackey, T.K., et al., Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment. The American journal of tropical medicine and hygiene, 2015. 92(Suppl 6): p. 59.

Lee, J.Y., et al., Underweight and mortality. Public Health Nutr, 2016. 19(10): p. 1751-6.

Park, J., et al., Underweight as a risk factor for vertebral fractures in the South Korean population. Spine J, 2023.

Mak, K.K. and S.H. Tan, Underweight problems in Asian children and adolescents. Eur J Pediatr, 2012. 171(5): p. 779-85.

Pourabdian, S., P. Golshiri, and M. Janghorbani, Overweight, underweight, and obesity among male long-distance professional drivers in Iran. J Occup Health, 2020. 62(1): p. e12114.

Mohseni, M., et al., A Systematic Review and Meta-Analysis of the Prevalence of Malnutrition Among 6-14-Year-Old Children in Iran. Int J Prev Med, 2022. 13: p. 138.

Jalali-Farahani, S., et al., Body mass index (BMI)-for-age and health-related quality of life (HRQOL) among high school students in Tehran. Child Care Health Dev, 2014. 40(5): p. 731-9.

Emamian, M.H., H. Hashemi, and A. Fotouhi, Obesity and underweight: Serious health problems in Iranian primary school children. Pediatr Int, 2019. 61(10): p. 1030-1035.

Fitzpatrick, K.K. and J. Lock, Anorexia nervosa. BMJ Clin Evid, 2011. 2011.

Halmi, K.A., et al., Anorexia Nervosa: Treatment Efficacy of Cyproheptadine and Amitriptyline. Archives of General Psychiatry, 1986. 43(2): p. 177-181.

Görög, S., Identification in drug quality control and drug research. TrAC Trends in Analytical Chemistry, 2015. 69: p. 114-122.

Zhang, J., et al., Quality of herbal medicines: challenges and solutions. Complementary therapies in medicine, 2012. 20(1-2): p. 100-106.

Organization, W.H., Guidelines for the appropriate use of herbal medicines. 1998.

Margine, I., et al., Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity. PLoS One, 2012. 7(12): p. e51559.

Organization, W.H., WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. 2004: World Health Organization.

Calapai, G., European legislation on herbal medicines: a look into the future. Drug Saf, 2008. 31(5): p. 428-31.

Mortazavi, S.M.J., et al., Unapproved Weight Gain Supplement as a Cause of Avascular Necrosis: A Cautionary Report. Arch Bone Jt Surg, 2019. 7(6): p. 561-565.

Saberi, N., et al., Determination of synthetic pharmaceutical adulterants in herbal weight gain supplements sold in herb shops, Tehran, Iran. Daru, 2018. 26(2): p. 117-127.

Bogusz, M.J., M. al Tufail, and H. Hassan, How natural are 'natural herbal remedies'? A Saudi perspective. Adverse Drug React Toxicol Rev, 2002. 21(4): p. 219-29.

Coghlan, M.L., et al., Combined DNA, toxicological and heavy metal analyses provides an auditing toolkit to improve pharmacovigilance of traditional Chinese medicine (TCM). Sci Rep, 2015. 5: p. 17475.

Leslie, W.S., C.R. Hankey, and M.E. Lean, Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review. QJM: An International Journal of Medicine, 2007. 100(7): p. 395-404.

Harrison, M.E., et al., Use of cyproheptadine to stimulate appetite and body weight gain: A systematic review. Appetite, 2019. 137: p. 62-72.

Couluris, M., et al., The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia. J Pediatr Hematol Oncol, 2008. 30(11): p. 791-7.

Sant'Anna, A.M., et al., Use of cyproheptadine in young children with feeding difficulties and poor growth in a pediatric feeding program. J Pediatr Gastroenterol Nutr, 2014. 59(5): p. 674-8.

McEvoy, G.K., AHFS drug information, 2000. 2000: American society of health-system pharmacists.

Moffat, A.C., et al., Clarke's analysis of drugs and poisons. 4 ed. Vol. 3. 2011: Pharmaceutical press London.

Graudins, A., A. Stearman, and B. Chan, Treatment of the serotonin syndrome with cyproheptadine. The Journal of emergency medicine, 1998. 16(4): p. 615-619.

Kumar, V.V. and K.R. Devi, Acute cyproheptadine poisoning. The Indian Journal of Pediatrics, 1989. 56(4): p. 521-523.

Levine, B., et al., A cyproheptadine fatality. Journal of analytical toxicology, 1998. 22(1): p. 72-74.